Healthcare Distribution Alliance – Patients Move Us.
Share Print


HDMA's Gray Testifies on Rx Drug Abuse Before House Subcommittee

April 7, 2014

ARLINGTON, Va. — HDMA President and CEO John M. Gray released the following statement on House legislation to address the inappropriate use of prescription medicines — the Ensuring Patient Access and Effective Drug Enforcement Act of 2014, H.R. 4069, sponsored by Reps. Marino (R-Pa.) and Blackburn (R-Tenn.) Mr. Gray testified on the legislation today before the House Energy and Commerce Subcommittee on Health at a hearing on "Improving Predictability and Transparency in DEA and FDA Regulation."

"The Marino-Blackburn legislation will further define key terminology in the Controlled Substances Act (CSA), so companies registered with the Drug Enforcement Administration (DEA) have clearer direction of their responsibilities under the law. A key provision allows DEA-registered companies to establish corrective action plans to address and mitigate any agency concerns — similar to the way FDA interacts and regulates pharmaceutical manufacturers — so industry and regulators can partner to address drug abuse and diversion.

"HDMA and our primary healthcare distributor members are working to identify collaborative and transparent solutions, in partnership with our supply chain trading partners and government officials, to slow the prescription drug abuse epidemic in our country, and the Marino-Blackburn bill is one step in our efforts to achieve that goal."

John Gray’s testimony is available through the HDMA website. For further HDMA resources on prescription drug abuse, see the Association's "Guiding Industry Principles on Prescription Drug Abuse and Diversion" and the fact sheet, "Fighting an Epidemic."


HDA is the national association representing primary healthcare distributors, the vital link between the nation’s pharmaceutical manufacturers and healthcare providers. Each business day, HDA member companies ensure that over 15 million prescription medicines and healthcare products are delivered safely and efficiently to more than 200,000 pharmacies, hospitals, long-term care facilities, clinics and others nationwide. HDA and its members work daily to provide value and achieve cost savings, an estimated $42 billion each year to our nation’s healthcare system.


Website design and development by, inc
© 2018 Healthcare Distribution Alliance. All rights reserved.
HDA: M | C | D | NF | O365